Huntsman Ronald Kirk 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 5:42 pm Purchase |
2023-12-31 | 13G | Vivos Therapeutics, Inc. VVOS |
Huntsman Ronald Kirk | 94,794 4.300% |
94,794 (New Position) |
Filing |